FLGT
Price
$17.03
Change
-$0.60 (-3.40%)
Updated
Jan 22, 04:22 PM (EDT)
Capitalization
648.84M
36 days until earnings call
NEO
Price
$14.52
Change
+$0.34 (+2.40%)
Updated
Jan 22, 04:58 PM (EDT)
Capitalization
2.01B
34 days until earnings call
Ad is loading...

FLGT vs NEO

Header iconFLGT vs NEO Comparison
Open Charts FLGT vs NEOBanner chart's image
Fulgent Genetics
Price$17.03
Change-$0.60 (-3.40%)
Volume$310
Capitalization648.84M
NeoGenomics
Price$14.52
Change+$0.34 (+2.40%)
Volume$900
Capitalization2.01B
FLGT vs NEO Comparison Chart
Loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FLGT vs. NEO commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLGT is a Hold and NEO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (FLGT: $17.63 vs. NEO: $14.18)
Brand notoriety: FLGT and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FLGT: 101% vs. NEO: 97%
Market capitalization -- FLGT: $648.84M vs. NEO: $2.01B
FLGT [@Medical Specialties] is valued at $648.84M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLGT’s FA Score shows that 1 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • FLGT’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, FLGT is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLGT’s TA Score shows that 3 TA indicator(s) are bullish while NEO’s TA Score has 3 bullish TA indicator(s).

  • FLGT’s TA Score: 3 bullish, 3 bearish.
  • NEO’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, NEO is a better buy in the short-term than FLGT.

Price Growth

FLGT (@Medical Specialties) experienced а +2.92% price change this week, while NEO (@Medical Specialties) price change was +2.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.41%. For the same industry, the average monthly price growth was +6.27%, and the average quarterly price growth was +2.26%.

Reported Earning Dates

FLGT is expected to report earnings on May 02, 2025.

NEO is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.41% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than FLGT($649M). NEO has higher P/E ratio than FLGT: NEO (49.50) vs FLGT (7.33). FLGT YTD gains are higher at: -4.548 vs. NEO (-13.956). NEO has higher annual earnings (EBITDA): -17.61M vs. FLGT (-49.15M). FLGT (424M) and NEO (415M) have equal amount of cash in the bank . FLGT has less debt than NEO: FLGT (15.3M) vs NEO (612M). NEO has higher revenues than FLGT: NEO (592M) vs FLGT (289M).
FLGTNEOFLGT / NEO
Capitalization649M2.01B32%
EBITDA-49.15M-17.61M279%
Gain YTD-4.548-13.95633%
P/E Ratio7.3349.5015%
Revenue289M592M49%
Total Cash424M415M102%
Total Debt15.3M612M3%
FUNDAMENTALS RATINGS
FLGT vs NEO: Fundamental Ratings
FLGT
NEO
OUTLOOK RATING
1..100
5718
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
8460
P/E GROWTH RATING
1..100
7100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FLGT's Valuation (54) in the Medical Or Nursing Services industry is in the same range as NEO (70). This means that FLGT’s stock grew similarly to NEO’s over the last 12 months.

FLGT's Profit vs Risk Rating (96) in the Medical Or Nursing Services industry is in the same range as NEO (100). This means that FLGT’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as FLGT (94). This means that NEO’s stock grew similarly to FLGT’s over the last 12 months.

NEO's Price Growth Rating (60) in the Medical Or Nursing Services industry is in the same range as FLGT (84). This means that NEO’s stock grew similarly to FLGT’s over the last 12 months.

FLGT's P/E Growth Rating (7) in the Medical Or Nursing Services industry is significantly better than the same rating for NEO (100). This means that FLGT’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FLGTNEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 15 days ago
78%
Momentum
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
76%
MACD
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 15 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
75%
Bullish Trend 15 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 15 days ago
82%
Bullish Trend 15 days ago
75%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 15 days ago
68%
Aroon
ODDS (%)
Bearish Trend 15 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIFLX14.410.21
+1.48%
Lord Abbett Focused Large Cap Value I
IVFIX3.730.05
+1.36%
Federated Hermes Intl Strat Val Div IS
READX12.090.12
+1.00%
Lazard Emerging Markets Eq Advtg R6
GCIAX13.67N/A
N/A
Goldman Sachs Intl Eq Insghts A
PJFPX69.58N/A
N/A
PGIM Jennison Growth R4

FLGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLGT has been loosely correlated with CTKB. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGT jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLGT
1D Price
Change %
FLGT100%
+3.10%
CTKB - FLGT
44%
Loosely correlated
+7.69%
NEO - FLGT
42%
Loosely correlated
-0.21%
NVST - FLGT
41%
Loosely correlated
+3.63%
BIO - FLGT
41%
Loosely correlated
+3.34%
CERS - FLGT
41%
Loosely correlated
+3.35%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-0.21%
FLGT - NEO
42%
Loosely correlated
+3.10%
VCYT - NEO
41%
Loosely correlated
+7.44%
HBIO - NEO
40%
Loosely correlated
+1.04%
AORT - NEO
39%
Loosely correlated
+2.83%
RDNT - NEO
38%
Loosely correlated
+0.55%
More